| 标题 |
 Fixed-duration pirtobrutinib plus venetoclax–rituximab versus venetoclax–rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊：The Lancet 作者：Matthew S Davids; Toby A Eyre; Jennifer A Woyach; Lindsey E Roeker; Alessandra Ferrajoli; et al 出版日期：2026-07-01 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)
null
kaio_escolar
呆萌的xue
mmmm
eni233
酸味yjm
GingerF
失眠的夜香
雪之下
饱满书雁
v0id
xiaoyinni
cocohan
无极微光
arniu2008
JerryPanJ
吃葡萄不吐葡萄皮
朱帅
初景
mmyhn
皖公网安备34019202002308
